

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.46222713 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.46222713 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 4.04567285 |
| 4 | cullin deneddylation (GO:0010388) | 4.02199757 |
| 5 | purine nucleobase biosynthetic process (GO:0009113) | 3.80595579 |
| 6 | proteasome assembly (GO:0043248) | 3.78138631 |
| 7 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.77966683 |
| 8 | proline biosynthetic process (GO:0006561) | 3.77451469 |
| 9 | protein deneddylation (GO:0000338) | 3.73091188 |
| 10 | nucleobase biosynthetic process (GO:0046112) | 3.72515704 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.72207950 |
| 12 | DNA deamination (GO:0045006) | 3.67816066 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 3.56024554 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.53582259 |
| 15 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.50690060 |
| 16 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.48946526 |
| 17 | GDP-mannose metabolic process (GO:0019673) | 3.45739193 |
| 18 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.40960060 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.39836271 |
| 20 | L-methionine salvage (GO:0071267) | 3.39775993 |
| 21 | L-methionine biosynthetic process (GO:0071265) | 3.39775993 |
| 22 | amino acid salvage (GO:0043102) | 3.39775993 |
| 23 | oxidative phosphorylation (GO:0006119) | 3.39566995 |
| 24 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.38295078 |
| 25 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33827925 |
| 26 | protein retention in ER lumen (GO:0006621) | 3.31224068 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.28031123 |
| 28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.26336805 |
| 29 | negative regulation of ligase activity (GO:0051352) | 3.26336805 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.25889694 |
| 31 | protein targeting to ER (GO:0045047) | 3.25783670 |
| 32 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.24631844 |
| 33 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.22178822 |
| 34 | galactose catabolic process (GO:0019388) | 3.20806642 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20371382 |
| 36 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.19387086 |
| 37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.14404380 |
| 38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.14404380 |
| 39 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.11404570 |
| 40 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.11404570 |
| 41 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.11404570 |
| 42 | protein localization to endoplasmic reticulum (GO:0070972) | 3.10839744 |
| 43 | negative regulation of cell size (GO:0045792) | 3.09303522 |
| 44 | pinocytosis (GO:0006907) | 3.09295813 |
| 45 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.08878823 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.07285498 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.07285498 |
| 48 | viral transcription (GO:0019083) | 3.07076354 |
| 49 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.05870735 |
| 50 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.05228923 |
| 51 | translational elongation (GO:0006414) | 3.03839073 |
| 52 | translation (GO:0006412) | 3.03401074 |
| 53 | ribosomal large subunit biogenesis (GO:0042273) | 3.02419415 |
| 54 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.02390597 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98056006 |
| 56 | nucleoside salvage (GO:0043174) | 2.97644414 |
| 57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.97380479 |
| 58 | translational termination (GO:0006415) | 2.97358589 |
| 59 | angiotensin maturation (GO:0002003) | 2.93113914 |
| 60 | tricarboxylic acid cycle (GO:0006099) | 2.92464310 |
| 61 | pentose-phosphate shunt (GO:0006098) | 2.90453196 |
| 62 | translational initiation (GO:0006413) | 2.90063345 |
| 63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.88934633 |
| 64 | oxaloacetate metabolic process (GO:0006107) | 2.88845611 |
| 65 | positive regulation of ligase activity (GO:0051351) | 2.87329673 |
| 66 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.85421121 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84150511 |
| 68 | transcription from mitochondrial promoter (GO:0006390) | 2.83538561 |
| 69 | regulation of vitamin metabolic process (GO:0030656) | 2.82273235 |
| 70 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.81606336 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78136029 |
| 72 | folic acid metabolic process (GO:0046655) | 2.77263936 |
| 73 | viral mRNA export from host cell nucleus (GO:0046784) | 2.77164686 |
| 74 | ribosomal small subunit biogenesis (GO:0042274) | 2.74948005 |
| 75 | fructose metabolic process (GO:0006000) | 2.74402207 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.73707485 |
| 77 | COPII vesicle coating (GO:0048208) | 2.73627671 |
| 78 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.73530478 |
| 79 | rRNA modification (GO:0000154) | 2.72110818 |
| 80 | nucleotide salvage (GO:0043173) | 2.70654485 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.68713002 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.68713002 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 2.67658093 |
| 84 | signal peptide processing (GO:0006465) | 2.67594652 |
| 85 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.67116368 |
| 86 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.67116368 |
| 87 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67057891 |
| 88 | IMP biosynthetic process (GO:0006188) | 2.66898012 |
| 89 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.66537691 |
| 90 | methionine biosynthetic process (GO:0009086) | 2.64546853 |
| 91 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.64431337 |
| 92 | proline metabolic process (GO:0006560) | 2.64167142 |
| 93 | positive regulation of cell cycle arrest (GO:0071158) | 2.63897018 |
| 94 | ATP synthesis coupled proton transport (GO:0015986) | 2.63574191 |
| 95 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.63574191 |
| 96 | glucose catabolic process (GO:0006007) | 2.63403767 |
| 97 | response to type I interferon (GO:0034340) | 2.62899789 |
| 98 | purine nucleotide salvage (GO:0032261) | 2.62298305 |
| 99 | negative regulation of viral release from host cell (GO:1902187) | 2.61784332 |
| 100 | urea cycle (GO:0000050) | 2.61688366 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.60854169 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.60854169 |
| 103 | peptide catabolic process (GO:0043171) | 2.59669841 |
| 104 | regulation of ligase activity (GO:0051340) | 2.59458835 |
| 105 | sexual reproduction (GO:0019953) | 2.58935325 |
| 106 | branched-chain amino acid catabolic process (GO:0009083) | 2.58849832 |
| 107 | sulfur amino acid biosynthetic process (GO:0000097) | 2.58426822 |
| 108 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.57941962 |
| 109 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.57792199 |
| 110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57524495 |
| 111 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56675219 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 2.53407306 |
| 113 | NADPH regeneration (GO:0006740) | 2.52427185 |
| 114 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.51833792 |
| 115 | viral life cycle (GO:0019058) | 2.50798853 |
| 116 | NADH metabolic process (GO:0006734) | 2.50684932 |
| 117 | glycine metabolic process (GO:0006544) | 2.50411756 |
| 118 | autophagic vacuole fusion (GO:0000046) | 2.49990529 |
| 119 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.48431511 |
| 120 | pentose metabolic process (GO:0019321) | 2.48262329 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 2.48079878 |
| 122 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.47962127 |
| 123 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.47962127 |
| 124 | intestinal cholesterol absorption (GO:0030299) | 2.46735397 |
| 125 | mannose metabolic process (GO:0006013) | 2.45578073 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45468687 |
| 127 | ribosome biogenesis (GO:0042254) | 2.45438647 |
| 128 | spliceosomal snRNP assembly (GO:0000387) | 2.45277258 |
| 129 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45276759 |
| 130 | urea metabolic process (GO:0019627) | 2.44591175 |
| 131 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.44535354 |
| 132 | folic acid transport (GO:0015884) | 2.44119301 |
| 133 | L-phenylalanine metabolic process (GO:0006558) | 2.43839511 |
| 134 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.43839511 |
| 135 | tRNA aminoacylation for protein translation (GO:0006418) | 2.43166869 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.42793347 |
| 137 | amino acid activation (GO:0043038) | 2.42683811 |
| 138 | tRNA aminoacylation (GO:0043039) | 2.42683811 |
| 139 | cellular metabolic compound salvage (GO:0043094) | 2.42406647 |
| 140 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.41647296 |
| 141 | glucose 6-phosphate metabolic process (GO:0051156) | 2.41085447 |
| 142 | adhesion of symbiont to host (GO:0044406) | 2.37829353 |
| 143 | T cell apoptotic process (GO:0070231) | 2.34108129 |
| 144 | regulation of viral release from host cell (GO:1902186) | 2.31807828 |
| 145 | tricarboxylic acid metabolic process (GO:0072350) | 2.30818985 |
| 146 | amyloid precursor protein catabolic process (GO:0042987) | 2.29888209 |
| 147 | positive regulation of histone deacetylation (GO:0031065) | 2.28591667 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.28134482 |
| 149 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.26820734 |
| 150 | glutathione biosynthetic process (GO:0006750) | 2.26231940 |
| 151 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.23331362 |
| 152 | response to peptidoglycan (GO:0032494) | 2.23059627 |
| 153 | leukocyte apoptotic process (GO:0071887) | 2.22508947 |
| 154 | adhesion of symbiont to host cell (GO:0044650) | 2.22485894 |
| 155 | virion attachment to host cell (GO:0019062) | 2.22485894 |
| 156 | cellular response to virus (GO:0098586) | 2.22229046 |
| 157 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.20151403 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.20132312 |
| 159 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.19322574 |
| 160 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.19035984 |
| 161 | interferon-gamma secretion (GO:0072643) | 2.18532470 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.18254655 |
| 163 | regulation of cholesterol storage (GO:0010885) | 2.17947767 |
| 164 | lymphocyte apoptotic process (GO:0070227) | 2.15033990 |
| 165 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.14993425 |
| 166 | regulation of chemokine biosynthetic process (GO:0045073) | 2.13985479 |
| 167 | modulation by virus of host process (GO:0019054) | 2.13495013 |
| 168 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.13410462 |
| 169 | cellular response to exogenous dsRNA (GO:0071360) | 2.13378302 |
| 170 | regulation of cholesterol metabolic process (GO:0090181) | 2.12945838 |
| 171 | cellular response to interferon-beta (GO:0035458) | 2.12818314 |
| 172 | maternal placenta development (GO:0001893) | 2.12609572 |
| 173 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.09471743 |
| 174 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.09269147 |
| 175 | nitric oxide biosynthetic process (GO:0006809) | 2.09147752 |
| 176 | phospholipid efflux (GO:0033700) | 2.09039848 |
| 177 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.08657660 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.08184730 |
| 179 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.07189431 |
| 180 | response to interferon-beta (GO:0035456) | 2.06603288 |
| 181 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.06259781 |
| 182 | mRNA modification (GO:0016556) | 2.05928955 |
| 183 | vagina development (GO:0060068) | 2.05829014 |
| 184 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.05440647 |
| 185 | activation of MAPKKK activity (GO:0000185) | 2.02981901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.76832680 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.48244574 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.26817009 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.21264163 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.06213340 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.83133117 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76946277 |
| 8 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.75976481 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.74116500 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.73707278 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.67378122 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.59552645 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50156687 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.48580819 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.38375099 |
| 16 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35774182 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32631506 |
| 18 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.30199832 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25069952 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20527101 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19920282 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.19020091 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17540217 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.16621079 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16191432 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.15344316 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.07643833 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.04177869 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97252535 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.95549651 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93416191 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.90618881 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.87844613 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87842556 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.86725014 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84466153 |
| 37 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.83028745 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.78207387 |
| 39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.74643764 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73886774 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70671709 |
| 42 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70518346 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70462568 |
| 44 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.69817400 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.69507177 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68590032 |
| 47 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.68046796 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65691815 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64665264 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64398580 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.59962095 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.58715029 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.58005597 |
| 54 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57812592 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57368272 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54599312 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.51855731 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51762211 |
| 59 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.49465024 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48223017 |
| 61 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.48152390 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47945674 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46714999 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45645188 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44915064 |
| 66 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44671707 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44176212 |
| 68 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44038662 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43797495 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43538154 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43510239 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43154786 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42086683 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40585172 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.39473267 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38721926 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37733153 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34290074 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33759538 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33600868 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33045163 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32451895 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.32129661 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30635913 |
| 85 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.29912890 |
| 86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29762554 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.29325469 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27652639 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27189786 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26249075 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26247098 |
| 92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25777043 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24123228 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23584400 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23474322 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23373813 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22502883 |
| 98 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21705400 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21445503 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21415704 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20737509 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20696687 |
| 103 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20473480 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19872998 |
| 105 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19642789 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19609868 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19405872 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19277735 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18254169 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17437022 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16276389 |
| 112 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.16237688 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15940939 |
| 114 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15731772 |
| 115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15675730 |
| 116 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15278441 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15276457 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14906071 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.14789496 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12919803 |
| 121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12489774 |
| 122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12289197 |
| 123 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10689281 |
| 124 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.10514495 |
| 125 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10318276 |
| 126 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10185820 |
| 127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09483700 |
| 128 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08976090 |
| 129 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08794318 |
| 130 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08182981 |
| 131 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07900309 |
| 132 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07704220 |
| 133 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07031474 |
| 134 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07011730 |
| 135 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06834209 |
| 136 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06112403 |
| 137 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05802846 |
| 138 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05742743 |
| 139 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05223711 |
| 140 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04850054 |
| 141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04445062 |
| 142 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03356499 |
| 143 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03235409 |
| 144 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03118987 |
| 145 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.03080784 |
| 146 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01686094 |
| 147 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01425553 |
| 148 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00566872 |
| 149 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00478362 |
| 150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.00072279 |
| 151 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99758345 |
| 152 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98776699 |
| 153 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98494536 |
| 154 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97466737 |
| 155 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97154179 |
| 156 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96952817 |
| 157 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96626526 |
| 158 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96517703 |
| 159 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96295303 |
| 160 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96248345 |
| 161 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95671818 |
| 162 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.92470298 |
| 163 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.91619011 |
| 164 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89913690 |
| 165 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88316590 |
| 166 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88316590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.10096768 |
| 2 | MP0005451_abnormal_body_composition | 3.68781533 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.07480353 |
| 4 | MP0001873_stomach_inflammation | 2.48342462 |
| 5 | MP0010030_abnormal_orbit_morphology | 2.45567797 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.43516724 |
| 7 | MP0005365_abnormal_bile_salt | 2.38338420 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.34398766 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.21788719 |
| 10 | MP0005360_urolithiasis | 2.19914851 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.11075390 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.10857326 |
| 13 | MP0003186_abnormal_redox_activity | 2.03554427 |
| 14 | MP0001666_abnormal_nutrient_absorption | 1.99864520 |
| 15 | MP0006054_spinal_hemorrhage | 1.93244267 |
| 16 | MP0009840_abnormal_foam_cell | 1.87990009 |
| 17 | MP0003436_decreased_susceptibility_to | 1.84413667 |
| 18 | MP0003123_paternal_imprinting | 1.81640813 |
| 19 | MP0009278_abnormal_bone_marrow | 1.78732899 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.78619740 |
| 21 | MP0010155_abnormal_intestine_physiology | 1.76877190 |
| 22 | MP0008260_abnormal_autophagy | 1.71037399 |
| 23 | MP0005410_abnormal_fertilization | 1.67623273 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.66773814 |
| 25 | MP0001849_ear_inflammation | 1.64655433 |
| 26 | MP0005083_abnormal_biliary_tract | 1.64611180 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.63898706 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.62343557 |
| 29 | MP0002796_impaired_skin_barrier | 1.61759461 |
| 30 | MP0003303_peritoneal_inflammation | 1.61204198 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.60614101 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.58937467 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.58285923 |
| 34 | MP0008007_abnormal_cellular_replicative | 1.56205526 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.55695405 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.55109692 |
| 37 | MP0009785_altered_susceptibility_to | 1.54287108 |
| 38 | MP0008932_abnormal_embryonic_tissue | 1.53269518 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.52414558 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.52360772 |
| 41 | MP0005025_abnormal_response_to | 1.51654897 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.51079820 |
| 43 | MP0004947_skin_inflammation | 1.48008149 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.47558648 |
| 45 | MP0003077_abnormal_cell_cycle | 1.47295650 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.45267236 |
| 47 | MP0001764_abnormal_homeostasis | 1.42982510 |
| 48 | MP0001730_embryonic_growth_arrest | 1.41153097 |
| 49 | MP0000685_abnormal_immune_system | 1.39891516 |
| 50 | MP0005387_immune_system_phenotype | 1.38746929 |
| 51 | MP0001790_abnormal_immune_system | 1.38746929 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.36641790 |
| 53 | MP0003279_aneurysm | 1.34284080 |
| 54 | MP0005332_abnormal_amino_acid | 1.30646826 |
| 55 | MP0003195_calcinosis | 1.29597820 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29309352 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.28347693 |
| 58 | MP0002254_reproductive_system_inflammat | 1.26849206 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.25933156 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.25681553 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.24919926 |
| 62 | MP0003119_abnormal_digestive_system | 1.23385291 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.22038885 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.21857661 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.21023157 |
| 66 | MP0005275_abnormal_skin_tensile | 1.20704279 |
| 67 | MP0009053_abnormal_anal_canal | 1.20613217 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19320408 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.19101944 |
| 70 | MP0002269_muscular_atrophy | 1.18750257 |
| 71 | MP0004133_heterotaxia | 1.18518740 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.18048632 |
| 73 | MP0008058_abnormal_DNA_repair | 1.18022926 |
| 74 | MP0001756_abnormal_urination | 1.17236774 |
| 75 | MP0000749_muscle_degeneration | 1.17202548 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.16877633 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.16877633 |
| 78 | MP0001853_heart_inflammation | 1.15960692 |
| 79 | MP0004233_abnormal_muscle_weight | 1.15422982 |
| 80 | MP0008469_abnormal_protein_level | 1.14675229 |
| 81 | MP0005670_abnormal_white_adipose | 1.13728832 |
| 82 | MP0004510_myositis | 1.11763986 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.11758042 |
| 84 | MP0004043_abnormal_pH_regulation | 1.11694138 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.10254420 |
| 86 | MP0001533_abnormal_skeleton_physiology | 1.09849303 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.09626848 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.08550616 |
| 89 | MP0003786_premature_aging | 1.08175394 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.07956565 |
| 91 | MP0000358_abnormal_cell_content/ | 1.07728222 |
| 92 | MP0005501_abnormal_skin_physiology | 1.07579118 |
| 93 | MP0005671_abnormal_response_to | 1.07385797 |
| 94 | MP0001800_abnormal_humoral_immune | 1.07044871 |
| 95 | MP0002419_abnormal_innate_immunity | 1.06869205 |
| 96 | MP0001697_abnormal_embryo_size | 1.06383109 |
| 97 | MP0003718_maternal_effect | 1.06153936 |
| 98 | MP0003984_embryonic_growth_retardation | 1.04941361 |
| 99 | MP0010094_abnormal_chromosome_stability | 1.04672734 |
| 100 | MP0002452_abnormal_antigen_presenting | 1.04595573 |
| 101 | MP0002723_abnormal_immune_serum | 1.04581052 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 1.04456082 |
| 103 | MP0003283_abnormal_digestive_organ | 1.02609484 |
| 104 | MP0005380_embryogenesis_phenotype | 1.02410521 |
| 105 | MP0001672_abnormal_embryogenesis/_devel | 1.02410521 |
| 106 | MP0002080_prenatal_lethality | 1.02019497 |
| 107 | MP0000750_abnormal_muscle_regeneration | 1.00653897 |
| 108 | MP0004272_abnormal_basement_membrane | 0.99250222 |
| 109 | MP0005266_abnormal_metabolism | 0.99122235 |
| 110 | MP0005503_abnormal_tendon_morphology | 0.97626244 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.97370954 |
| 112 | MP0001881_abnormal_mammary_gland | 0.96959650 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.95621881 |
| 114 | MP0003075_altered_response_to | 0.94914878 |
| 115 | MP0003315_abnormal_perineum_morphology | 0.94839075 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.94707138 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.94683129 |
| 118 | MP0005166_decreased_susceptibility_to | 0.93972883 |
| 119 | MP0001819_abnormal_immune_cell | 0.93556204 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.93494253 |
| 121 | MP0000678_abnormal_parathyroid_gland | 0.92809318 |
| 122 | MP0006035_abnormal_mitochondrial_morpho | 0.92578353 |
| 123 | MP0009115_abnormal_fat_cell | 0.92404126 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.91996320 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.91486917 |
| 126 | MP0005408_hypopigmentation | 0.90780153 |
| 127 | MP0009697_abnormal_copulation | 0.90504766 |
| 128 | MP0005023_abnormal_wound_healing | 0.90255212 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.89613536 |
| 130 | MP0000858_altered_metastatic_potential | 0.89023391 |
| 131 | MP0003566_abnormal_cell_adhesion | 0.88858898 |
| 132 | MP0000598_abnormal_liver_morphology | 0.88716280 |
| 133 | MP0002060_abnormal_skin_morphology | 0.88281292 |
| 134 | MP0000490_abnormal_crypts_of | 0.88015020 |
| 135 | MP0002132_abnormal_respiratory_system | 0.86494136 |
| 136 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86339565 |
| 137 | MP0009333_abnormal_splenocyte_physiolog | 0.86312934 |
| 138 | MP0002837_dystrophic_cardiac_calcinosis | 0.85878404 |
| 139 | MP0001216_abnormal_epidermal_layer | 0.85332203 |
| 140 | MP0003866_abnormal_defecation | 0.84975500 |
| 141 | MP0002877_abnormal_melanocyte_morpholog | 0.84273402 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.84147511 |
| 143 | MP0003011_delayed_dark_adaptation | 0.83652396 |
| 144 | MP0002098_abnormal_vibrissa_morphology | 0.83157470 |
| 145 | MP0000609_abnormal_liver_physiology | 0.83107362 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.82383664 |
| 147 | MP0003942_abnormal_urinary_system | 0.82309486 |
| 148 | MP0005330_cardiomyopathy | 0.81889592 |
| 149 | MP0001663_abnormal_digestive_system | 0.81845104 |
| 150 | MP0000681_abnormal_thyroid_gland | 0.81743445 |
| 151 | MP0002398_abnormal_bone_marrow | 0.81199710 |
| 152 | MP0000462_abnormal_digestive_system | 0.81026781 |
| 153 | MP0009931_abnormal_skin_appearance | 0.80328926 |
| 154 | MP0002127_abnormal_cardiovascular_syste | 0.79794255 |
| 155 | MP0002085_abnormal_embryonic_tissue | 0.79419914 |
| 156 | MP0000716_abnormal_immune_system | 0.79310104 |
| 157 | MP0002429_abnormal_blood_cell | 0.78920848 |
| 158 | MP0002086_abnormal_extraembryonic_tissu | 0.77966895 |
| 159 | MP0002998_abnormal_bone_remodeling | 0.77785250 |
| 160 | MP0003890_abnormal_embryonic-extraembry | 0.77563932 |
| 161 | MP0009780_abnormal_chondrocyte_physiolo | 0.77335482 |
| 162 | MP0005376_homeostasis/metabolism_phenot | 0.77179714 |
| 163 | MP0003252_abnormal_bile_duct | 0.77112738 |
| 164 | MP0000350_abnormal_cell_proliferation | 0.76963466 |
| 165 | MP0001542_abnormal_bone_strength | 0.76850849 |
| 166 | MP0005058_abnormal_lysosome_morphology | 0.76081075 |
| 167 | MP0005257_abnormal_intraocular_pressure | 0.75667226 |
| 168 | MP0002295_abnormal_pulmonary_circulatio | 0.75526598 |
| 169 | MP0004197_abnormal_fetal_growth/weight/ | 0.75270053 |
| 170 | MP0001243_abnormal_dermal_layer | 0.75052164 |
| 171 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74491765 |
| 172 | MP0000003_abnormal_adipose_tissue | 0.74345010 |
| 173 | MP0000343_altered_response_to | 0.73615631 |
| 174 | MP0005636_abnormal_mineral_homeostasis | 0.73393505 |
| 175 | MP0002970_abnormal_white_adipose | 0.73102038 |
| 176 | MP0002722_abnormal_immune_system | 0.71752445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.10669296 |
| 2 | Multiple enchondromatosis (HP:0005701) | 3.44066478 |
| 3 | Hepatic necrosis (HP:0002605) | 3.43075666 |
| 4 | Asymmetric septal hypertrophy (HP:0001670) | 3.19302083 |
| 5 | J-shaped sella turcica (HP:0002680) | 3.12225535 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11761626 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09194192 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.08334158 |
| 9 | Abnormality of the anterior horn cell (HP:0006802) | 2.98691363 |
| 10 | Degeneration of anterior horn cells (HP:0002398) | 2.98691363 |
| 11 | Dicarboxylic aciduria (HP:0003215) | 2.97056045 |
| 12 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97056045 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 2.88426892 |
| 14 | Hepatocellular necrosis (HP:0001404) | 2.78265502 |
| 15 | Hyperglycinuria (HP:0003108) | 2.78104822 |
| 16 | Hyperglycinemia (HP:0002154) | 2.73520811 |
| 17 | Aplastic anemia (HP:0001915) | 2.72443496 |
| 18 | Thin bony cortex (HP:0002753) | 2.69210637 |
| 19 | Generalized aminoaciduria (HP:0002909) | 2.65021246 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63697024 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63697024 |
| 22 | Trismus (HP:0000211) | 2.63178588 |
| 23 | Protrusio acetabuli (HP:0003179) | 2.63025435 |
| 24 | Deep venous thrombosis (HP:0002625) | 2.61811080 |
| 25 | Cerebral hypomyelination (HP:0006808) | 2.60192527 |
| 26 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60184339 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59840224 |
| 28 | Opisthotonus (HP:0002179) | 2.59626908 |
| 29 | Ketosis (HP:0001946) | 2.57450268 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.56143021 |
| 31 | Increased serum pyruvate (HP:0003542) | 2.55786035 |
| 32 | Abnormality of glycolysis (HP:0004366) | 2.55786035 |
| 33 | Ketoacidosis (HP:0001993) | 2.53679412 |
| 34 | Secondary amenorrhea (HP:0000869) | 2.52186185 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.52122294 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.50791257 |
| 37 | Cholecystitis (HP:0001082) | 2.50791257 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.50663790 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.49929765 |
| 40 | Myopathic facies (HP:0002058) | 2.49686738 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.49326597 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.49326597 |
| 43 | Palpitations (HP:0001962) | 2.47175076 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.46452041 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.44143265 |
| 46 | Hyperglycemia (HP:0003074) | 2.43817787 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.43735557 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43304260 |
| 49 | Late onset (HP:0003584) | 2.43033938 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.42664163 |
| 51 | Increased serum lactate (HP:0002151) | 2.42039795 |
| 52 | Lethargy (HP:0001254) | 2.41824118 |
| 53 | Increased CSF lactate (HP:0002490) | 2.39377581 |
| 54 | Increased serum ferritin (HP:0003281) | 2.36642922 |
| 55 | Bulbar palsy (HP:0001283) | 2.36543831 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.36476165 |
| 57 | Hyperammonemia (HP:0001987) | 2.35480553 |
| 58 | CNS demyelination (HP:0007305) | 2.34743142 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.33815408 |
| 60 | Hypertensive crisis (HP:0100735) | 2.31396170 |
| 61 | Abnormal protein glycosylation (HP:0012346) | 2.31358088 |
| 62 | Abnormal glycosylation (HP:0012345) | 2.31358088 |
| 63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31358088 |
| 64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31358088 |
| 65 | Hemorrhage of the eye (HP:0011885) | 2.31164855 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30839980 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.30781829 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30390957 |
| 69 | Stridor (HP:0010307) | 2.30163870 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.29422367 |
| 71 | Ileus (HP:0002595) | 2.28944078 |
| 72 | Exercise-induced myalgia (HP:0003738) | 2.28811949 |
| 73 | Neoplasm of the adrenal gland (HP:0100631) | 2.28271327 |
| 74 | Acute encephalopathy (HP:0006846) | 2.27832595 |
| 75 | Myoglobinuria (HP:0002913) | 2.25644705 |
| 76 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25010243 |
| 77 | Diaphragmatic weakness (HP:0009113) | 2.23479809 |
| 78 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.20422664 |
| 79 | Abdominal distention (HP:0003270) | 2.18593702 |
| 80 | Nonimmune hydrops fetalis (HP:0001790) | 2.17855800 |
| 81 | Cerebral edema (HP:0002181) | 2.16879147 |
| 82 | Lactic acidosis (HP:0003128) | 2.16564840 |
| 83 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.16217306 |
| 84 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.16217306 |
| 85 | Right ventricular cardiomyopathy (HP:0011663) | 2.15426535 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 2.13724395 |
| 87 | Prolonged neonatal jaundice (HP:0006579) | 2.12679037 |
| 88 | Colitis (HP:0002583) | 2.12455521 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11160004 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11160004 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11160004 |
| 92 | Selective tooth agenesis (HP:0001592) | 2.10773915 |
| 93 | Abnormal hemoglobin (HP:0011902) | 2.10772359 |
| 94 | Seborrheic dermatitis (HP:0001051) | 2.10622234 |
| 95 | Abnormal pancreas size (HP:0012094) | 2.10365227 |
| 96 | Nausea (HP:0002018) | 2.09597835 |
| 97 | Rough bone trabeculation (HP:0100670) | 2.09472500 |
| 98 | Loss of speech (HP:0002371) | 2.09399567 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 2.07831248 |
| 100 | Glycosuria (HP:0003076) | 2.07831248 |
| 101 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.06850796 |
| 102 | Mucopolysacchariduria (HP:0008155) | 2.06208649 |
| 103 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06208649 |
| 104 | Glomerulonephritis (HP:0000099) | 2.04435188 |
| 105 | 11 pairs of ribs (HP:0000878) | 2.04308642 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04004833 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04004833 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04004833 |
| 109 | Asymmetry of the thorax (HP:0001555) | 2.03426684 |
| 110 | Premature ovarian failure (HP:0008209) | 2.03043149 |
| 111 | B lymphocytopenia (HP:0010976) | 2.02389541 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 2.01198216 |
| 113 | Premature rupture of membranes (HP:0001788) | 2.00754209 |
| 114 | Emotional lability (HP:0000712) | 1.99971522 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.99203844 |
| 116 | Achilles tendon contracture (HP:0001771) | 1.98956932 |
| 117 | Beaking of vertebral bodies (HP:0004568) | 1.98575408 |
| 118 | Microretrognathia (HP:0000308) | 1.98080780 |
| 119 | Polygenic inheritance (HP:0010982) | 1.97325960 |
| 120 | Hyperparathyroidism (HP:0000843) | 1.96866303 |
| 121 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95987289 |
| 122 | Testicular atrophy (HP:0000029) | 1.95973651 |
| 123 | Abnormality of complement system (HP:0005339) | 1.95870144 |
| 124 | Flat acetabular roof (HP:0003180) | 1.95616036 |
| 125 | Progressive muscle weakness (HP:0003323) | 1.94561082 |
| 126 | Hypophosphatemia (HP:0002148) | 1.92840449 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.91759389 |
| 128 | Recurrent viral infections (HP:0004429) | 1.91097100 |
| 129 | Vertebral compression fractures (HP:0002953) | 1.89706190 |
| 130 | Malnutrition (HP:0004395) | 1.89237872 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 1.89091626 |
| 132 | Hydroxyprolinuria (HP:0003080) | 1.89091626 |
| 133 | Respiratory failure (HP:0002878) | 1.88828174 |
| 134 | Thrombocytosis (HP:0001894) | 1.88414004 |
| 135 | Cervical subluxation (HP:0003308) | 1.88125066 |
| 136 | Carpal bone hypoplasia (HP:0001498) | 1.87929549 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.86915730 |
| 138 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86859904 |
| 139 | Villous atrophy (HP:0011473) | 1.85573804 |
| 140 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.85573804 |
| 141 | Neuroendocrine neoplasm (HP:0100634) | 1.84967410 |
| 142 | Gout (HP:0001997) | 1.84848591 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 1.84761382 |
| 144 | Hypertriglyceridemia (HP:0002155) | 1.84372521 |
| 145 | Exercise intolerance (HP:0003546) | 1.83152021 |
| 146 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82997538 |
| 147 | Breast hypoplasia (HP:0003187) | 1.82406240 |
| 148 | Axonal loss (HP:0003447) | 1.80662202 |
| 149 | Complement deficiency (HP:0004431) | 1.80448613 |
| 150 | Abnormality of B cell number (HP:0010975) | 1.79754494 |
| 151 | Redundant skin (HP:0001582) | 1.79537094 |
| 152 | Abnormality of serum amino acid levels (HP:0003112) | 1.79393757 |
| 153 | Hyperacusis (HP:0010780) | 1.79071372 |
| 154 | Reticulocytosis (HP:0001923) | 1.76890545 |
| 155 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76618872 |
| 156 | Pheochromocytoma (HP:0002666) | 1.76225059 |
| 157 | Missing ribs (HP:0000921) | 1.75505788 |
| 158 | Vomiting (HP:0002013) | 1.75272500 |
| 159 | Poor head control (HP:0002421) | 1.74746231 |
| 160 | Petechiae (HP:0000967) | 1.74706400 |
| 161 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74131677 |
| 162 | Methylmalonic aciduria (HP:0012120) | 1.73393581 |
| 163 | Obstructive lung disease (HP:0006536) | 1.73355568 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73355568 |
| 165 | Gastrointestinal inflammation (HP:0004386) | 1.72109392 |
| 166 | Reticulocytopenia (HP:0001896) | 1.72005180 |
| 167 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71785657 |
| 168 | Gastrointestinal dysmotility (HP:0002579) | 1.71751146 |
| 169 | Increased muscle lipid content (HP:0009058) | 1.71601259 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.70977616 |
| 171 | Elevated alkaline phosphatase (HP:0003155) | 1.69065898 |
| 172 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67348210 |
| 173 | Eczematoid dermatitis (HP:0000976) | 1.67227199 |
| 174 | Distal upper limb amyotrophy (HP:0007149) | 1.66721027 |
| 175 | Upper limb amyotrophy (HP:0009129) | 1.66721027 |
| 176 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.64137817 |
| 177 | Easy fatigability (HP:0003388) | 1.63748452 |
| 178 | Abnormality of the nasal mucosa (HP:0000433) | 1.62761037 |
| 179 | Abnormal trabecular bone morphology (HP:0100671) | 1.61064189 |
| 180 | Esophageal varix (HP:0002040) | 1.60769869 |
| 181 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.60593360 |
| 182 | Abnormality of the thoracic spine (HP:0100711) | 1.60587708 |
| 183 | Panhypogammaglobulinemia (HP:0003139) | 1.59534010 |
| 184 | Emphysema (HP:0002097) | 1.59462465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.06017313 |
| 2 | BUB1 | 3.47342834 |
| 3 | EIF2AK1 | 3.06235473 |
| 4 | SMG1 | 3.04418434 |
| 5 | ERN1 | 2.96969614 |
| 6 | PASK | 2.91103903 |
| 7 | TESK1 | 2.60097608 |
| 8 | MAP4K1 | 2.53661995 |
| 9 | STK16 | 2.53564303 |
| 10 | SIK1 | 2.49189978 |
| 11 | NME2 | 2.33287282 |
| 12 | EPHA2 | 2.18650321 |
| 13 | TBK1 | 2.09928078 |
| 14 | FLT3 | 2.07054326 |
| 15 | FGFR4 | 2.03214657 |
| 16 | PRPF4B | 2.01176111 |
| 17 | PDK4 | 1.95059546 |
| 18 | PDK3 | 1.95059546 |
| 19 | TESK2 | 1.87625537 |
| 20 | PIK3CG | 1.85452993 |
| 21 | WEE1 | 1.81448108 |
| 22 | EIF2AK3 | 1.79941303 |
| 23 | STK38L | 1.72900946 |
| 24 | DYRK3 | 1.68389713 |
| 25 | NEK1 | 1.67720608 |
| 26 | MST1R | 1.66975406 |
| 27 | TRIB3 | 1.60688420 |
| 28 | VRK2 | 1.60511788 |
| 29 | TLK1 | 1.59543798 |
| 30 | PDK2 | 1.57090586 |
| 31 | LIMK1 | 1.55709431 |
| 32 | RIPK1 | 1.55581918 |
| 33 | MYLK | 1.54076038 |
| 34 | MAP3K11 | 1.53631064 |
| 35 | NME1 | 1.49015286 |
| 36 | NEK9 | 1.47699451 |
| 37 | EEF2K | 1.40204280 |
| 38 | WNK3 | 1.39866469 |
| 39 | MAP3K10 | 1.36884860 |
| 40 | RPS6KB2 | 1.34865070 |
| 41 | TYK2 | 1.30484314 |
| 42 | PIM2 | 1.28117737 |
| 43 | MUSK | 1.26306899 |
| 44 | PAK4 | 1.24801934 |
| 45 | RPS6KA4 | 1.24511358 |
| 46 | ICK | 1.22089855 |
| 47 | MAP2K2 | 1.21641833 |
| 48 | IKBKE | 1.16883725 |
| 49 | KDR | 1.15106710 |
| 50 | PDPK1 | 1.14956245 |
| 51 | PKN2 | 1.12954804 |
| 52 | MAPKAPK3 | 1.12287429 |
| 53 | ILK | 1.08219250 |
| 54 | MAPK15 | 1.08105581 |
| 55 | MAP3K14 | 1.07194052 |
| 56 | IKBKB | 1.04195600 |
| 57 | EPHB2 | 1.03589543 |
| 58 | TSSK6 | 1.01787906 |
| 59 | MAP3K1 | 0.99877555 |
| 60 | MAP3K3 | 0.99337267 |
| 61 | CDK7 | 0.99280954 |
| 62 | PRKD2 | 0.98642420 |
| 63 | LATS2 | 0.98037946 |
| 64 | ZAK | 0.96352981 |
| 65 | PRKCI | 0.96322460 |
| 66 | RIPK4 | 0.95815863 |
| 67 | LMTK2 | 0.95069885 |
| 68 | TAOK1 | 0.93938285 |
| 69 | PTK6 | 0.92746036 |
| 70 | BRAF | 0.92531682 |
| 71 | OBSCN | 0.92459061 |
| 72 | AURKA | 0.91872446 |
| 73 | PLK1 | 0.91607121 |
| 74 | MET | 0.90739236 |
| 75 | TTN | 0.90486578 |
| 76 | NEK2 | 0.90089429 |
| 77 | RPS6KC1 | 0.87802382 |
| 78 | RPS6KL1 | 0.87802382 |
| 79 | AURKB | 0.85870548 |
| 80 | MAP3K13 | 0.85418924 |
| 81 | GRK6 | 0.85232541 |
| 82 | PLK4 | 0.85034957 |
| 83 | AKT3 | 0.84891188 |
| 84 | DYRK1B | 0.83909431 |
| 85 | TGFBR1 | 0.83623081 |
| 86 | TTK | 0.82029746 |
| 87 | JAK3 | 0.80480668 |
| 88 | IRAK3 | 0.80375680 |
| 89 | PAK1 | 0.79643494 |
| 90 | RPS6KA2 | 0.79234314 |
| 91 | CDK4 | 0.78364576 |
| 92 | PTK2 | 0.78265256 |
| 93 | ZAP70 | 0.74291297 |
| 94 | PDK1 | 0.74227319 |
| 95 | DYRK2 | 0.73011066 |
| 96 | CHUK | 0.70956364 |
| 97 | CDK12 | 0.69902096 |
| 98 | BRSK2 | 0.69294956 |
| 99 | ARAF | 0.68478199 |
| 100 | MAP3K8 | 0.66577370 |
| 101 | DAPK3 | 0.66396973 |
| 102 | ABL2 | 0.66233913 |
| 103 | RPS6KA6 | 0.65758455 |
| 104 | LRRK2 | 0.65460131 |
| 105 | MAP2K3 | 0.65366451 |
| 106 | HIPK2 | 0.65079071 |
| 107 | PRKG2 | 0.61680236 |
| 108 | PDGFRA | 0.61524733 |
| 109 | CSF1R | 0.61354069 |
| 110 | VRK1 | 0.60727955 |
| 111 | SCYL2 | 0.60515505 |
| 112 | INSRR | 0.58638197 |
| 113 | CSNK2A1 | 0.55860146 |
| 114 | TIE1 | 0.55282641 |
| 115 | CHEK2 | 0.54901920 |
| 116 | NLK | 0.53880526 |
| 117 | DDR2 | 0.53792474 |
| 118 | ATR | 0.52740099 |
| 119 | CDC42BPA | 0.52618823 |
| 120 | NUAK1 | 0.52011870 |
| 121 | PAK2 | 0.51774130 |
| 122 | DAPK1 | 0.51047552 |
| 123 | IRAK4 | 0.49971599 |
| 124 | EPHB1 | 0.49263762 |
| 125 | MAP2K1 | 0.48249080 |
| 126 | MAP2K6 | 0.48086810 |
| 127 | SRPK1 | 0.47579161 |
| 128 | PBK | 0.47136202 |
| 129 | PAK3 | 0.46261258 |
| 130 | BMX | 0.45095879 |
| 131 | MTOR | 0.43040520 |
| 132 | MAPK7 | 0.40945998 |
| 133 | PRKD3 | 0.40678342 |
| 134 | TNK2 | 0.40555306 |
| 135 | CDK9 | 0.39206961 |
| 136 | BTK | 0.38705033 |
| 137 | PINK1 | 0.38541813 |
| 138 | KIT | 0.38328330 |
| 139 | CSNK2A2 | 0.37747445 |
| 140 | MAP3K12 | 0.37532082 |
| 141 | BRSK1 | 0.37383490 |
| 142 | IRAK2 | 0.36658423 |
| 143 | PIK3CA | 0.36491761 |
| 144 | MATK | 0.36470995 |
| 145 | FGFR3 | 0.35037350 |
| 146 | FER | 0.34814057 |
| 147 | SIK3 | 0.34476134 |
| 148 | PLK3 | 0.33104547 |
| 149 | MST4 | 0.32965875 |
| 150 | CAMK2G | 0.32537977 |
| 151 | MAPK11 | 0.32119742 |
| 152 | ERBB3 | 0.31368216 |
| 153 | MAPK4 | 0.30792044 |
| 154 | TAOK2 | 0.30365548 |
| 155 | MAPKAPK2 | 0.30028702 |
| 156 | RPS6KA1 | 0.28398465 |
| 157 | DMPK | 0.27148205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.49633812 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.70759712 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.64037014 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.59631107 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.29045296 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23288628 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.11056667 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.07286908 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.98427069 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.96085891 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.93367834 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82826284 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.81445217 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80808901 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79317451 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79274892 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.75562984 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.73201002 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71992193 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66554930 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.64158058 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62000353 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60489648 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58466300 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55671523 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53190404 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51580221 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50753378 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49572133 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.48760376 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48724331 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48523300 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47979781 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46903195 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44741614 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.44370548 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.38994844 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38838081 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38535121 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36872381 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.35182911 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.34840110 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33812583 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32862716 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32093550 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.28591673 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.24115248 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21169405 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21104928 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.20092014 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.18283073 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18019807 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12022503 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07213238 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07143077 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05194411 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.05079441 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04948791 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04850781 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 1.04817470 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04719600 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03079787 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02961856 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01710759 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00150073 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99980831 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97902553 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96199427 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95612403 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94800060 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94296952 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94270684 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92986006 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91760888 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.90879092 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.90033298 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89944512 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89783933 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89779697 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.89282301 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87962993 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85835149 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85124486 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85097277 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83259942 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81078294 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80829466 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79261224 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79058071 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78330389 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77497002 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77282681 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76368339 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76328166 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.76104405 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75360311 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74896687 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74785943 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74597448 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73112425 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72466403 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70749086 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.70424221 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70271391 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70190853 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69663345 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69206770 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68056352 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67550681 |
| 110 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67396242 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66949809 |
| 112 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66763970 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65113131 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64304345 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63745162 |
| 116 | Measles_Homo sapiens_hsa05162 | 0.61120463 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60706518 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60701250 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60646130 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.58988632 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.58160645 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.57437452 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57318146 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57191240 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.55780893 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52454660 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.52138808 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51797697 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51490511 |
| 130 | Apoptosis_Homo sapiens_hsa04210 | 0.49288538 |
| 131 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48411061 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47804659 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47111683 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46340057 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45933195 |
| 136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45587910 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45444005 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44422478 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43639685 |
| 140 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42788998 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42674018 |
| 142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42657878 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.42656558 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41206655 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40698736 |
| 146 | Shigellosis_Homo sapiens_hsa05131 | 0.40305002 |
| 147 | Bladder cancer_Homo sapiens_hsa05219 | 0.39543035 |
| 148 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39027611 |
| 149 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38039480 |
| 150 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36031434 |
| 151 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32107558 |
| 152 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.30394353 |

